Liang Zou

发表

Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism

Jianbo Xiao, Feiya Sheng, Songsong Wang, 2021, Journal of advanced research.

Intrarenal 1-methoxypyrene, an aryl hydrocarbon receptor agonist, mediates progressive tubulointerstitial fibrosis in mice

Yan Guo, N. Vaziri, Hua Miao, 2022, Acta Pharmacologica Sinica.

Buxue Yimu Pills improve angiogenesis and blood flow in experimental zebrafish and rat models.

Peng Li, Mengyao Wu, Yan He, 2022, Journal of ethnopharmacology.

Integrative phosphatidylcholine metabolism through phospholipase A2 in rats with chronic kidney disease

Zhichao Guo, Yamei Zhang, Yan-ni Wang, 2022, Acta Pharmacologica Sinica.

Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy

Ying-yong Zhao, Hua Miao, Xiaoyong Yu, 2022, Frontiers in Pharmacology.

Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities.

Hua Miao, Ting-ting Duan, Yingliang Zhao, 2022, Chemico-biological interactions.

DNAzyme-based biosensors for mercury (Ⅱ) detection: Rational construction, advances and perspectives.

Peng Li, Jinchao Wei, Ting Wang, 2022, Journal of hazardous materials.

Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway

Xiao-yong Yu, Yan-ni Wang, Yingliang Zhao, 2022, Frontiers in Pharmacology.

A comprehensive review on the medicinal usage of Podocarpus species: Phytochemistry and pharmacology.

Yi Liu, Si-Yu Yang, Le-Le Zhang, 2023, Journal of ethnopharmacology.

Integrative transcriptomics and proteomics analyses to reveal the therapeutic effect and mechanism of Buxue Yimu Pills in medical-induced incomplete abortion rats.

P. Zhang, Mengyao Wu, Wei Li, 2022, Journal of ethnopharmacology.

Identification of potential quality markers of Zishen Yutai pill based on spectrum–effect relationship analysis

Jiliang Cao, Lele Yang, Na Ning, 2023, Frontiers in Pharmacology.

Membranous nephropathy: Mechanistic insights and therapeutic perspectives.

Xia Li, Yan-long Zhao, Yingliang Zhao, 2023, International immunopharmacology.

Bile acid metabolism in health and ageing-related diseases.

Hua Miao, Yingliang Zhao, Liang Zou, 2024, Biochemical pharmacology.

The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis

Hua Miao, Yan-long Zhao, Yingliang Zhao, 2024, Frontiers in pharmacology.

Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan‐produced indole metabolites

Yan Guo, Hua Miao, Wei Su, 2023, British journal of pharmacology.

Arachidonic acid metabolism as a therapeutic target in AKI-to-CKD transition

Hua Miao, Yan-ni Wang, Yingliang Zhao, 2024, Frontiers in pharmacology.